Cite
Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models.
MLA
Tada, Takuya, et al. “Checkpoint Inhibitor-Expressing Lentiviral Vaccine Suppresses Tumor Growth in Preclinical Cancer Models.” Journal for Immunotherapy of Cancer, vol. 12, no. 4, Apr. 2024. EBSCOhost, https://doi.org/10.1136/jitc-2023-008761.
APA
Tada, T., Norton, T. D., Leibowitz, R., & Landau, N. R. (2024). Checkpoint inhibitor-expressing lentiviral vaccine suppresses tumor growth in preclinical cancer models. Journal for Immunotherapy of Cancer, 12(4). https://doi.org/10.1136/jitc-2023-008761
Chicago
Tada, Takuya, Thomas D Norton, Rebecca Leibowitz, and Nathaniel R Landau. 2024. “Checkpoint Inhibitor-Expressing Lentiviral Vaccine Suppresses Tumor Growth in Preclinical Cancer Models.” Journal for Immunotherapy of Cancer 12 (4). doi:10.1136/jitc-2023-008761.